Demo mode. In production, this would be authentication-driven. Each role sees only what's relevant to their workflow.
VL
Vivre Labs
Institutional Longevity
- Peptides -
- Single-vial Blends -
- Goals -
- Clinical Reference -
- Guides -
- Integrity -
Single-Vial Blend · One Injection
◐
KLOW
GLOW, plus inflammatory control.
KLOW is GLOW with KPV added - the same recovery foundation (BPC-157 + TB-500 + GHK-Cu) plus KPV for inflammatory modulation, pre-blended into one injection. For patients whose recovery is complicated by chronic or systemic inflammation.
BPC-157TB-500GHK-CuKPV
◆ Certificate of Analysis · KLOW
JANOSHIK ANALYTICALHPLC + MS · Independent third-party
Lot-specific COAs for KLOW are published with each batch release. Sample certificates available on request via partnerships@vivrelabs.com.
KLOW · product
$355/mo
Founder rate · locked 12 months · one injection
Physician-prescribed after a baseline screen. The Audit determines fit.
For
·Patients with recovery needs compounded by chronic inflammation
·Those who want the GLOW foundation with an added anti-inflammatory layer
·Patients who prefer one injection over separate compounds
Not for
·Patients without an inflammatory component (standard GLOW may fit better)
·Anyone needing the full biomarker-monitored protocol
·Active malignancy, pregnancy, or uncontrolled bleeding disorders
The KLOW blend is one injection, verified and lot-tested. Biomarker monitoring, physician consults, and dose adjustments are available through Membership (available to partner practices, free for Batch 001) - or upload your own labs for an AI educational summary at no cost. Clinical care is delivered and billed by the partner facility; Vivre does not mark up your clinical care. Physician determines suitability at consultation.